Intellectual Property India Publishes Patent Application for 'Phospholipid Ether Conjugates As Cancer-Targeting Drug Vehicles' Filed by Cellectar Biosciences, Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202518097764 A) filed by Cellectar Biosciences, Inc.Florham Park, U.S.A., on Oct. 10, for 'phospholipid ether conjugates as cancer-targeting drug vehicles.'

Inventor(s) include Longcor, Jarrod; Pinchuk, Anatoly; Hoover, Randall; and Huang, Zhongping.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "Disclosed herein are therapeutic compounds capable of targeting a broad range of tumor cells. The present disclosure is further directed to compositions comprising the therapeutic compounds, methods of manufacturing the therapeutic compounds, and metho...